SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-002105
Filing Date
2018-01-12
Accepted
2018-01-12 16:15:20
Documents
8
Period of Report
2018-01-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv483219_8k.htm 8-K 23784
2 EXHIBIT 5.1 tv483219_ex5-1.htm EX-5.1 10289
3 EXHIBIT 99.1 tv483219_ex99-1.htm EX-99.1 45274
4 EXHIBIT 99.2 tv483219_ex99-2.htm EX-99.2 190792
5 EXHIBIT 99.3 tv483219_ex99-3.htm EX-99.3 10218
6 EXHIBIT 99.4 tv483219_ex99-4.htm EX-99.4 10050
7 GRAPHIC image_001.jpg GRAPHIC 9462
8 GRAPHIC image_002.jpg GRAPHIC 21023
  Complete submission text file 0001144204-18-002105.txt   333860
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 18526142
SIC: 2836 Biological Products, (No Diagnostic Substances)